NCT05250908
INTIBIA Pivotal Study
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 17 versions: 15 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 34 words
- Study completion pushed from Jun 27, 2026 to Jun 2029
- Site details revised at 2 of 22 sites
- Study description expanded, about 3 words
- Minor Primary completion date: Jun 27, 2025 to May 12, 2025v16
- Notable Enrollment target: 108 to 208
- Primary completion date: May 5, 2025 to Jun 27, 2025
- Study completion date: May 5, 2026 to Jun 27, 2026
- Minor Trial status: Recruiting to Active, Not Recruiting
- Enrollment target: estimated 225 to confirmed 108
- Study sites: 24 to 22
- Notable Primary completion date: Mar 7, 2024 to May 5, 2025
- Study completion date: Mar 7, 2025 to May 5, 2026
Show 9 earlier versionsHide 9 earlier versions
- Minor Site contacts updated at 1 of 24 sitesv10
- Notable Eligibility criteria expanded, about 9 words
- Study sites: 19 to 24
- Minor Study sites: 18 to 19v8
- Minor Study sites: 15 to 18v7
- Minor Study sites: 11 to 15v6
- Minor Study sites: 6 to 11v5
- Minor Study sites: 2 to 6v4
- Minor Study sites: 1 to 2
- Primary completion date: Mar 1, 2024 to Mar 7, 2024
- Study completion date: Mar 1, 2025 to Mar 7, 2025
- Start date changed from estimate of Mar 1, 2022 to Mar 7, 2022
- Minor Secondary endpoints: details revised at 1 of 2 entriesv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Response Rate
Timeframe: 3 Months
Secondary (2)
Urgency Score
Daily Voids
Arms and interventions
INTIBIA TherapeuticExperimental
Implanted with INTIBIA device and programmed to therapeutic stimulation for the duration of the study.
INTIBIA Non-TherapeuticExperimental
Implanted with INTIBIA device and programmed to non-therapeutic stimulation for the first 3 months, then to therapeutic stimulation for the duration of the study.
Devices: INTIBIA Therapeutic, INTIBIA Non-Therapeutic
Sites
22 sites in 2 countries
United States 20, Netherlands 2